s-nitrosoglutathione has been researched along with Alveolar Bone Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldim, V; Bonfim, LE; Brito, GA; Costa, DV; G de Oliveira, M; Leitão, RF; Lima, V; Martins, CS; Melo, CB; Melo, IM; Santos, GS; Wong, DV | 1 |
| de Carvalho Leitão, RF; de Castro Brito, GA; de Menezes, AM; de Oliveira, MG; de Souza, GF; Gomes, AS; Ribeiro, Rde A | 1 |
2 other study(ies) available for s-nitrosoglutathione and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Disease Models, Animal; Gingiva; Hypromellose Derivatives; Inflammation; Interleukin-1beta; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Periodontal Diseases; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; S-Nitrosoglutathione; Solutions; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2016 |
S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats.
Topics: Alkaline Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents; Biomarkers; Bone Resorption; Disease Models, Animal; Gingiva; Injections; Interleukin-1beta; Lipid Peroxidation; Matrix Metalloproteinase Inhibitors; NF-kappa B; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Oxidative Stress; Periodontitis; Peroxidase; Pharmaceutic Aids; Povidone; Rats; Rats, Wistar; S-Nitrosoglutathione; Sodium Chloride; Tumor Necrosis Factor-alpha | 2012 |